1502TiP Paclitaxel + ramucirumab versus paclitaxel alone in patients with squamous-cell carcinoma of the esophagus, refractory or intolerant to combination therapy with fluoropyrimidine and platinum-based drugs - RAMOS, a randomized phase II trial of the German Gastric Group of the AIO
| Autor: | Lorenzen, S., Pauligk, C., Götze, T.O., Michael, C., Mahlberg, R.J.C., Schmalenberg, H., Biederstädt, A., Frost, G., Heidel, S., Treschl, A., Junge, S., Hofheinz, R.D., Moehler, M., Al-Batran, S-E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S931-S931 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|